These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38424636)

  • 21. A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.
    Liu S; Sun X; Wang M; Hou Y; Zhan Y; Jiang Y; Liu Z; Cao X; Chen P; Liu Z; Chen X; Tao Y; Xu C; Mao J; Cheng C; Li C; Hu Y; Wang L; Chin YE; Shi Y; Siebenlist U; Zhang X
    Gastroenterology; 2014 Oct; 147(4):847-859.e11. PubMed ID: 24931456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bufalin reverses cancer-associated fibroblast-mediated colorectal cancer metastasis by inhibiting the STAT3 signaling pathway.
    Wang H; Chen J; Li S; Yang J; Tang D; Wu W; Yu K; Cao Y; Xu K; Yin P; Chen Y; Li W
    Apoptosis; 2023 Apr; 28(3-4):594-606. PubMed ID: 36705874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.
    Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY
    Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA 452 regulates IL20RA-mediated JAK1/STAT3 pathway in inflammatory colitis and colorectal cancer.
    Lamichhane S; Mo JS; Sharma G; Choi TY; Chae SC
    Inflamm Res; 2021 Aug; 70(8):903-914. PubMed ID: 34283251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
    Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling.
    Zhong B; Cheng B; Huang X; Xiao Q; Niu Z; Chen YF; Yu Q; Wang W; Wu XJ
    Cell Death Dis; 2021 Dec; 13(1):16. PubMed ID: 34930899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.
    Srivatsa S; Paul MC; Cardone C; Holcmann M; Amberg N; Pathria P; Diamanti MA; Linder M; Timelthaler G; Dienes HP; Kenner L; Wrba F; Prager GW; Rose-John S; Eferl R; Liguori G; Botti G; Martinelli E; Greten FR; Ciardiello F; Sibilia M
    Gastroenterology; 2017 Jul; 153(1):178-190.e10. PubMed ID: 28400195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the isoflavone corylin from cullen corylifolium on colorectal cancer growth, by targeting the STAT3 signaling pathway.
    Yang L; Yao Y; Bai Y; Zheng D; Zhou F; Chen L; Hu W; Xiang Y; Zhao H; Liu Z; Wang L; Huang X; Zhao C
    Phytomedicine; 2021 Jan; 80():153366. PubMed ID: 33080566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review).
    Wang SW; Sun YM
    Int J Oncol; 2014 Apr; 44(4):1032-40. PubMed ID: 24430672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo.
    Yan S; Li Z; Thiele CJ
    Oncotarget; 2013 Mar; 4(3):433-45. PubMed ID: 23531921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer.
    Dobi E; Monnien F; Kim S; Ivanaj A; N'Guyen T; Demarchi M; Adotevi O; Thierry-Vuillemin A; Jary M; Kantelip B; Pivot X; Godet Y; Degano SV; Borg C
    Clin Colorectal Cancer; 2013 Mar; 12(1):28-36. PubMed ID: 23083634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis.
    Ye TH; Yang FF; Zhu YX; Li YL; Lei Q; Song XJ; Xia Y; Xiong Y; Zhang LD; Wang NY; Zhao LF; Gou HF; Xie YM; Yang SY; Yu LT; Yang L; Wei YQ
    Cell Death Dis; 2017 Jan; 8(1):e2534. PubMed ID: 28055016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the JAK-STAT3 pathway is associated with the growth of colorectal carcinoma cells.
    Wei X; Wang G; Li W; Hu X; Huang Q; Xu K; Lou W; Wu J; Liang C; Lou Q; Qian C; Liu L
    Oncol Rep; 2014 Jan; 31(1):335-41. PubMed ID: 24253664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma.
    Gordziel C; Bratsch J; Moriggl R; Knösel T; Friedrich K
    Br J Cancer; 2013 Jul; 109(1):138-46. PubMed ID: 23756862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ANXA4 Activates JAK-STAT3 Signaling by Interacting with ANXA1 in Basal-Like Breast Cancer.
    Li L; Zhang R; Liu Y; Zhang G
    DNA Cell Biol; 2020 Sep; 39(9):1649-1656. PubMed ID: 32552056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of SOCS3 and its biological function in colorectal cancer.
    Chu Q; Shen D; He L; Wang H; Liu C; Zhang W
    Gene; 2017 Sep; 627():114-122. PubMed ID: 28603075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis.
    Kobayashi H; Gieniec KA; Lannagan TRM; Wang T; Asai N; Mizutani Y; Iida T; Ando R; Thomas EM; Sakai A; Suzuki N; Ichinose M; Wright JA; Vrbanac L; Ng JQ; Goyne J; Radford G; Lawrence MJ; Sammour T; Hayakawa Y; Klebe S; Shin AE; Asfaha S; Bettington ML; Rieder F; Arpaia N; Danino T; Butler LM; Burt AD; Leedham SJ; Rustgi AK; Mukherjee S; Takahashi M; Wang TC; Enomoto A; Woods SL; Worthley DL
    Gastroenterology; 2022 Mar; 162(3):890-906. PubMed ID: 34883119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer.
    Zhang H; Zhao B; Wei H; Zeng H; Sheng D; Zhang Y
    J Ethnopharmacol; 2022 Apr; 287():114915. PubMed ID: 34954267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcuminoids Modulated the IL-6/JAK/STAT3 Signaling Pathway in LoVo and HT-29 Colorectal Cancer Cells.
    Li Q; Ding Y; Ou Y; Li M; Jithavech P; Buranasudja V; Sritularak B; Xu Y; Rojsitthisak P; Han J
    Curr Pharm Des; 2023; 29(36):2867-2876. PubMed ID: 37957863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.